Has Lance Pagliaro, MD received payments from drug or device companies?

Yes. Drug and device makers reported $18,378 in general payments to Lance Pagliaro, MD across 20 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lance Pagliaro, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lance Pagliaro, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lance Pagliaro, MD

Medical Oncology · Rochester, MNNPI 1568553311

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $16,573 of the $18,378 with a category attached, or 90.2%. Merck accounts for 78.6% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2019 at $9,305 and has fallen 77.1% since, to $2,135 in 2022.

$18,378in general payments, 2019–2025

Across 20 payments — averaging $918.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$14K
Astellas Pharma Global Development$4K

$5,074,016in research payments, 2019–2025

Across 303 payments — averaging $16,746 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$2.1M
Astellas US Technologies$1.3M
Exelixis Inc.$1M
Astellas Pharma Global Development$512K
Merck$106K
Regeneron$37K
plus $23K from 1 others

What the payments were for

Consulting fees$16,57390%
Travel & lodging$1,4548%
Food & beverage$3512%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	18	$14,440
Astellas Pharma Global Development	2	$3,938

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PADCEV$3,938

How this compares

$18,378 in reported general payments places this provider in the 75th percentile of 133 medical oncology providers in Minnesota.

See all medical oncology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$995,170

Medicare patients

271

Services billed

33,904

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
XtandiEnzalutamide	65	$879,298
CabometyxCabozantinib S-Malate	27	$756,707
InlytaAxitinib	18	$338,977
ErleadaApalutamide	21	$330,340
Abiraterone Acetate	30	$134,117
Prochlorperazine Maleate	33	$382
Dexamethasone	43	$290
Olanzapine	40	$285
Ondansetron Hcl	39	$227
Oxycodone Hcl	19	$145
Prednisone	17	$122
Levothyroxine Sodium	11	$34

Paid to pharmacies, not to this prescriber.

Other medical oncology in Rochester

Amit MahipalRochester$746K
Alton SartorRochester$688K
Ben GeorgeRochester$579K
Elisabeth HeathRochester$236K
Matthew GoetzRochester$136K
Thorvardur HalfdanarsonRochester$86K
Harry YoonRochester$69K
Karthik GiridharRochester$66K
Joleen HubbardRochester$59K
Lionel Aurelien Kankeu FonkouaRochester$58K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →